Citations (113)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (17)
Einar-Jón Einarsson, Hannes Petersen, Thomas Wiebe, Per-Anders Fransson, Måns Magnusson & Christian Moëll. (2011) Severe difficulties with word recognition in noise after platinum chemotherapy in childhood, and improvements with open-fitting hearing-aids. International Journal of Audiology 50:10, pages 642-651.
Read now
Read now
Einar J. Einarsson, Hannes Petersen, Thomas Wiebe, Per A. Fransson, Jan Grenner, Måns Magnusson & Christer Moëll. (2010) Long term hearing degeneration after platinum-based chemotherapy in childhood. International Journal of Audiology 49:10, pages 765-771.
Read now
Read now
Samuel Ofori, Mary Ann Heddon & Martha Griffis. (2009) Toward a Risk-Based Assessment of the Adult Cancer Survivor: Late Effects of Chemotherapy. Hospital Practice 37:1, pages 113-120.
Read now
Read now
Sarah Kohn, Milo Fradis, Eliezer Robinson & Theodore C. Iancu. (2005) Hepatotoxicity of Combined Treatment with Cisplatin and Gentamicin in the Guinea Pig. Ultrastructural Pathology 29:2, pages 129-137.
Read now
Read now
Constance Visovsky$suffix/text()$suffix/text(). (2003) Chemotherapy-Induced Peripheral Neuropathy. Cancer Investigation 21:3, pages 439-451.
Read now
Read now
Albertina De Lauretis, Bruno De Capua, Maria Teresa Barbieri, Luisa Bellussi & Desiderio Passàli. (1999) ABR evaluation of ototoxicity in cancer patients receiving cisplatin or carboplatin. Scandinavian Audiology 28:3, pages 139-143.
Read now
Read now
Mark P. J. Yardley, Catherine M. Davies & John C. Stevens. (1998) Use of Transient Evoked Otoacoustic Emissions to Detect and Monitor Cochlear Damage Caused by Platinum-Containing Drugs. British Journal of Audiology 32:5, pages 305-316.
Read now
Read now
B. J. Kennedy & Jane L. Torkelson. (1998) Familial Hearing Loss and Cisplatin Therapy. Cancer Investigation 16:4, pages 213-216.
Read now
Read now
Sarah Kohn, Milo Fradis, Ludwig Podoshin, Jacob Ben-David, Jamal Zidan & Eliezer Robinson. (1997) Endothelial Injury of Capillaries in the Stria Vascularis of Guinea Pigs Treated with Cisplatin and Gentamicin. Ultrastructural Pathology 21:3, pages 289-299.
Read now
Read now
Donald Henderson & Malini Subramaniam. (1996) Advances in Our Understanding of Noise-Induced Hearing Loss. Applied Occupational and Environmental Hygiene 11:4, pages 255-260.
Read now
Read now
Miloš Taudy, Josef Syka, Jiši Popelář & Libuše Úlehlová. (1992) Carboplatin and Cisplatin Ototoxicity in Guinea Pigs: Les effets ototoxiques du cisplatine et du carboplatine chez le cobaye. Audiology 31:5, pages 293-299.
Read now
Read now
W. A. Dreschler, R.J.A.M. v.d. Hulst, R. A. Tange & N. A. M. Urbanus. (1989) Role of High-Frequency Audiometry in the Early Detection of Ototoxicity: II. Clinical Aspects. Audiology 28:4, pages 211-220.
Read now
Read now
J. P. Griffin. (1988) Drug-induced ototoxicity. British Journal of Audiology 22:3, pages 195-210.
Read now
Read now
Göran Laurell & Erik Borg. (1988) Ototoxicity of Cisplatin in Gynaecological Cancer Patients. Scandinavian Audiology 17:4, pages 241-247.
Read now
Read now
GÖRan Laurell & Erik Borg. (1986) Cis-Platin Ototoxicity in Previously Noise-Exposed Guinea Pigs. Acta Oto-Laryngologica 101:1-2, pages 66-74.
Read now
Read now
W. A. Dreschler, R.J.A.M. v.d. Hulst, R. A. Tange & N. A. M. Urbanus. (1985) The Role of High-Frequency Audiometry in Early Detection of Ototoxicity. Audiology 24:6, pages 387-395.
Read now
Read now
Y. Nakai, K. Konishi, K. C. Chang, K. Ohashi, N. Morisaki, Y. Minowa & A. Morimoto. (1982) Ototoxicity of the Anticancer Drug Cisplatin:An Experimental Study. Acta Oto-Laryngologica 93:1-6, pages 227-232.
Read now
Read now
Articles from other publishers (96)
Pooja D. Halani, Rajdeep J. Gupta, Akash M. Shah & Shirish S. Alurkar. (2022) Prospective Observational Study of Evaluating Cisplatin-Induced Ototoxicity in Patients. Indian Journal of Medical and Paediatric Oncology 43:05, pages 424-430.
Crossref
Crossref
Senthilvelan Manohar, Guang-Di Chen, Dalian Ding, Lijie Liu, Jian Wang, Yu-Chen Chen, Lin Chen & Richard Salvi. (2022) Unexpected Consequences of Noise-Induced Hearing Loss: Impaired Hippocampal Neurogenesis, Memory, and Stress. Frontiers in Integrative Neuroscience 16.
Crossref
Crossref
Leonard P. Rybak, Debashree Mukherjea & Vickram Ramkumar. 2022. Comprehensive Pharmacology. Comprehensive Pharmacology
732
754
.
Jessica Paken, Cyril D. Govender, Mershen Pillay, Birhanu T. Ayele & Vikash Sewram. (2021) Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity. BMC Women's Health 21:1.
Crossref
Crossref
Jessica Paken, Cyril D. Govender, Mershen Pillay, Birhanu T. Ayele & Vikash Sewram. (2021) Feasibility and first results of a prospective cohort study to investigate cisplatin-associated ototoxicity amongst cancer patients in South Africa. BMC Cancer 21:1.
Crossref
Crossref
Sudeep Madisetti. (2020) Audiological Evaluation and Analysis of Patients with Malignancy Treated with Cisplatin Chemotherapy. Journal of Evidence Based Medicine and Healthcare 7:30, pages 1490-1494.
Crossref
Crossref
Shlomit Yust-Katz, Simon Khagi & Mark R. Gilbert. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
688
706.e7
.
K. Fernandez, T. Wafa, T.S. Fitzgerald & L.L. Cunningham. (2019) An optimized, clinically relevant mouse model of cisplatin-induced ototoxicity. Hearing Research 375, pages 66-74.
Crossref
Crossref
Naoki Kohei, Kyohei Sugiyama, Ichiro Chihara, Yusuke Muro, Masaaki Imamura, Yasunori Nishio & Koji Yoshimura. (2018) Impact of relative dose intensity in gemcitabine–cisplatin chemotherapy for metastatic urothelial carcinoma. SAGE Open Medicine 6, pages 205031211878301.
Crossref
Crossref
Finja Thiermann & Gerhard Buchbauer. (2017) Influence of drugs on smelling capacity. A review. Flavour and Fragrance Journal 32:3, pages 147-158.
Crossref
Crossref
Jessica Paken, Cyril D. Govender, Mershen Pillay & Vikash Sewram. (2016) Cisplatin-Associated Ototoxicity: A Review for the Health Professional. Journal of Toxicology 2016, pages 1-13.
Crossref
Crossref
Pierluigi Benedetti Panici, Innocenza Palaia, Claudia Marchetti, Ilary Ruscito, Margherita Fischetti, Angela Musella, Violante Di Donato, Giorgia Perniola, Laura Vertechy & Ludovico Muzii. (2015) Dose-Dense Neoadjuvant Chemotherapy plus Radical Surgery in Locally Advanced Cervical Cancer: A Phase II Study. Oncology 89:2, pages 103-110.
Crossref
Crossref
Shlomit Yust-Katz & Mark R. Gilbert. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
822
844.e6
.
Sebastian Hoth, Katrin Neumann, Roland Mühler & Martin WalgerK. Neumann & M. Walger. 2014. Objektive Audiometrie im Kindesalter. Objektive Audiometrie im Kindesalter
183
323
.
Darren Lars Stirland, Joseph W. Nichols, Seiji Miura & You Han Bae. (2013) Mind the gap: A survey of how cancer drug carriers are susceptible to the gap between research and practice. Journal of Controlled Release 172:3, pages 1045-1064.
Crossref
Crossref
Mahmut Özkırış, Zeliha Kapusuz, Seyhan Karaçavuş & Levent Saydam. (2013) The effects of lycopene on cisplatin-induced ototoxicity. European Archives of Oto-Rhino-Laryngology 270:12, pages 3027-3033.
Crossref
Crossref
Anna L. Vlasits, Julian A. Simon, David W. Raible, Edwin W. Rubel & Kelly N. Owens. (2012) Screen of FDA-approved drug library reveals compounds that protect hair cells from aminoglycosides and cisplatin. Hearing Research 294:1-2, pages 153-165.
Crossref
Crossref
Miyuki Baba, Yu Matsumoto, Akinori Kashio, Horacio Cabral, Nobuhiro Nishiyama, Kazunori Kataoka & Tatsuya Yamasoba. (2012) Micellization of cisplatin (NC-6004) reduces its ototoxicity in guinea pigs. Journal of Controlled Release 157:1, pages 112-117.
Crossref
Crossref
Süleyman Yılmaz, Fatih Öktem & Emin Karaman. (2009) Detection of cisplatin-induced ototoxicity with transient evoked otoacoustic emission test before pure tone audiometer. European Archives of Oto-Rhino-Laryngology 267:7, pages 1041-1044.
Crossref
Crossref
K. Barabas, R. Milner, D. Lurie & C. Adin. (2008) Cisplatin: a review of toxicities and therapeutic applications. Veterinary and Comparative Oncology 6:1, pages 1-18.
Crossref
Crossref
Mark R. Gilbert. 2008. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
945
967
.
Henry C. Ou, David W. Raible & Edwin W. Rubel. (2007) Cisplatin-induced hair cell loss in zebrafish (Danio rerio) lateral line. Hearing Research 233:1-2, pages 46-53.
Crossref
Crossref
Najat C. Daw, Catherine A. Billups, Carlos Rodriguez-Galindo, M. Beth McCarville, Bhaskar N. Rao, Alvida M. Cain, Jesse J. Jenkins, Michael D. Neel & William H. Meyer. (2006) Metastatic osteosarcoma. Cancer 106:2, pages 403-412.
Crossref
Crossref
F. Liang, B.A. Schulte, C. Qu, W. Hu & Z. Shen. (2005) Inhibition of the calcium- and voltage-dependent big conductance potassium channel ameliorates cisplatin-induced apoptosis in spiral ligament fibrocytes of the cochlea. Neuroscience 135:1, pages 263-271.
Crossref
Crossref
Craig A. Whitworth, Vickram Ramkumar, Brett Jones, Naoki Tsukasaki & Leonard P. Rybak. (2004) Protection against cisplatin ototoxicity by adenosine agonists. Biochemical Pharmacology 67:9, pages 1801-1807.
Crossref
Crossref
Jake A. Gilbert, Amanda E. Simpson, David E. Rudnick, Dayle H. Geroski, Thomas M. AabergJr.Jr. & Henry F. Edelhauser. (2003) Transscleral permeability and intraocular concentrations of cisplatin from a collagen matrix. Journal of Controlled Release 89:3, pages 409-417.
Crossref
Crossref
Silvano Prosser. 2002. A Textbook of Audiological Medicine. A Textbook of Audiological Medicine
451
475
.
Daniel Kushev, Galina Gorneva, Venelin Enchev, Emilya Naydenova, Julita Popova, Svetoslav Taxirov, Liliana Maneva, Konstantin Grancharov & Nadejda Spassovska. (2002) Synthesis, cytotoxicity, antibacterial and antitumor activity of platinum(II) complexes of 3-aminocyclohexanespiro-5-hydantoin. Journal of Inorganic Biochemistry 89:3-4, pages 203-211.
Crossref
Crossref
N. Dehne, J. Lautermann, F. Petrat, U. Rauen & H. de Groot. (2001) Cisplatin Ototoxicity: Involvement of Iron and Enhanced Formation of Superoxide Anion Radicals. Toxicology and Applied Pharmacology 174:1, pages 27-34.
Crossref
Crossref
William H. MeyerCharles B. PrattCatherine A. PoquetteBhaskar N. RaoDavid M. ParhamNeyssa M. MarinaAlberto S. PappoHazem H. MahmoudJesse J. JenkinsJames HarperMichael NeelBarry D. Fletcher. (2001) Carboplatin/Ifosfamide Window Therapy for Osteosarcoma: Results of the St Jude Children’s Research Hospital OS-91 Trial. Journal of Clinical Oncology 19:1, pages 171-182.
Crossref
Crossref
Richard J. Salvi, Dalian Ding, Ann Clock Eddins, Sandra L. McFadden & Donald Henderson. 2001. Functional Neurobiology of Aging. Functional Neurobiology of Aging
549
563
.
R. Dauman & D. Dulon. (2000) Ototoxicidad medicamentosa. EMC - Otorrinolaringología 29:1, pages 1-12.
Crossref
Crossref
E. Cvitkovic. (1998) Cumulative toxicities from cisplatin therapy and current cytoprotective measures. Cancer Treatment Reviews 24:4, pages 265-281.
Crossref
Crossref
Lee M. Hilliard, Roger L. Berkow, Jan Watterson, Evan A. Ballard, Gene K. Balzer & Christopher L. Moertel. (1997) Retinal toxicity associated with cisplatin and etoposide in pediatric patients. Medical and Pediatric Oncology 28:4, pages 310-313.
Crossref
Crossref
Kay Rabbitt Park. (1996) The Utility of Acoustic Reflex Thresholds and Other Conventional Audiologic Tests for Monitoring Cisplatin Ototoxicity in the Pediatric Population. Ear and Hearing 17:2, pages 107-115.
Crossref
Crossref
Ronnie J. Freilich, Dennis H. Kraus, Amy S. Budnick, Lisa A. Bayer & Jonathan L. Finlay. (1996) Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue. Medical and Pediatric Oncology 26:2, pages 95-100.
Crossref
Crossref
John S. Rubin, Scott Wadler, Jonathan J. Baitler, Hilda Haynes, Alla Rozenblet, Frances McGill, Gary Goldberg & Carolyn Runowicz. (2007) Audiological findings in a Phase I protocol investigating the effect of WR 2721, high-dose cisplatin and radiation therapy in patients with locally advanced cervical carcinoma. The Journal of Laryngology & Otology 109:8, pages 744-747.
Crossref
Crossref
Malgorzata K. Tuxen & Steen Werner Hansen. (1994) Neurotoxicity secondary to antineoplastic drugs. Cancer Treatment Reviews 20:2, pages 191-214.
Crossref
Crossref
Elda Scherini & Graziella Bernocchi. (1994) CisDDP treatment and development of the rat cerebellum. Progress in Neurobiology 42:2, pages 161-196.
Crossref
Crossref
Nina Aass & Sophie D. Fosså. 1994. Germ Cell Tumours III. Germ Cell Tumours III
337
343
.
Vanessa Gayl Schweitzer. (1993) Ototoxicity of Chemotherapeutic Agents. Otolaryngologic Clinics of North America 26:5, pages 759-789.
Crossref
Crossref
Steven F. Myers, Brian W. Blakley & Sabina Schwan. (1993)
Is
Cis
‐Platinum Vestibulotoxic?
. Otolaryngology–Head and Neck Surgery 108:4, pages 322-328.
Crossref
Crossref
Vanessa Gayl Schweitzer. (1993) Cisplatin-Induced Ototoxicity: The Effect of Pigmentation and Inhibitory Agents. The Laryngoscope 103, pages 1-52.
Crossref
Crossref
Masahiro Kurisaka, Masahiko Arisawa, Akihito Moriki & Koreaki Mori. (1993) Successful combination chemotherapy (cisplatin, vinblastine, and bleomycin) with small-dose irradiation in the treatment of pineoblastoma metastasized into spinal cord: Case report. Surgical Neurology 39:2, pages 152-157.
Crossref
Crossref
P.G. Zorowka, H.J. Schmitt & P. Gutjahr. (1993) Evoked otoacoustic emissions and pure tone threshold audiometry in patients receiving cisplatinum therapy. International Journal of Pediatric Otorhinolaryngology 25:1-3, pages 73-80.
Crossref
Crossref
Robert A. Weatherly, Judith J. Owens, Francis I. Catlin & Donald H. Mahoney. (2009)
Cis
‐Platinum ototoxicity in children
. The Laryngoscope 101:9, pages 917-924.
Crossref
Crossref
Sarah Kohn, Milo Fradis, Ludwig Podoshin, Yaacov Ben David, Jamal Zidan, Eliezer Robinson & Izhak Nir. (1991) Toxic Effects of Cisplatin Alone and in Combination With Gentamicin in Stria Vascularis of Guinea Pigs. The Laryngoscope 101:7, pages 709???716.
Crossref
Crossref
Steven F. Myers, Brian W. Blakley, Sabina Schwan, William F. Rintelmann & Robert H. Mathog. (1991) The “plateau effect” of cis‐platinum‐induced hearing loss. Otolaryngology–Head and Neck Surgery 104:1, pages 122-127.
Crossref
Crossref
Penelope R. Brock, Susan C. Bellman, Elizabeth C. Yeomans, C. Ross Pinkerton & Jon Pritchard. (2006) Cisplatin ototoxicity in children: A practical grading system. Medical and Pediatric Oncology 19:4, pages 295-300.
Crossref
Crossref
Michael Anne Gratton, Richard J Salvi, Barton A Kamen & Samuel S Saunders. (1990) Interaction of cisplatin and noise on the peripheral auditory system. Hearing Research 50:1-2, pages 211-223.
Crossref
Crossref
B. Daunter & B.E. Cham. (1990) Solasodine glycosides. In vitro preferential cytotoxicity for human cancer cells. Cancer Letters 55:3, pages 209-220.
Crossref
Crossref
Göran Laurell & Ulf Jungnelius. (2009) High‐Dose cisplatin treatment: Hearing loss and plasma concentrations. The Laryngoscope 100:7, pages 724-734.
Crossref
Crossref
Michael P. Osborne & Spiro D. Comis. (2005) High resolution scanning electron microscopy of stereocilia in the cochlea of normal, postmortem, and drug‐treated guinea pigs. Journal of Electron Microscopy Technique 15:3, pages 245-260.
Crossref
Crossref
Ernest M. WalkerJr.Jr., Mary A. Fazekas-May & William R. Bowen. (1990) Nephrotoxic and Ototoxic Agents. Clinics in Laboratory Medicine 10:2, pages 323-354.
Crossref
Crossref
Ian C. S. Kennedy, Bernard M. Fitzharris, Barry M. Colls & Christopher H. Atkinson. (1990) Carboplatin is ototoxic. Cancer Chemotherapy and Pharmacology 26:3, pages 232-234.
Crossref
Crossref
May Y. Huang & Jochen Schacht. (2012) Drug-Induced Ototoxicity. Medical Toxicology and Adverse Drug Experience 4:6, pages 452-467.
Crossref
Crossref
A. Harstrick, J. Casper, R. Guba, H. Wilke, H. Poliwoda & H. J. Schmoll. (1989) Comparison of the antitumor activity of cisplatin, carboplatin, and iproplatin against established human testicular cancer cell linesin vivo andin vitro. Cancer 63:6, pages 1079-1083.
Crossref
Crossref
Charles L. Litterst & Eddie Reed. 1989. Cancer Management in Man. Cancer Management in Man
85
97
.
J. Syka. 1989. Progress in Sensory Physiology 9. Progress in Sensory Physiology 9
97
170
.
W.C Otto, R.D Brown, L Gage-White, S Kupetz, M Anniko, J.E Penny & C.M Henley. (1988) Effects of cisplatin and thiosulfate upon auditory brainstem responses of guinea pigs. Hearing Research 35:1, pages 79-85.
Crossref
Crossref
Sarah Kohn, Hillel Pratt, Eliezer Robinson, Izhak Nir, Milo Fradis, Ludwig Podoshin & Jamal Zidan. (2009) Cisplatin ototoxicity in guinea pigs with special reference to toxic effects in the stria vascularis. The Laryngoscope 98:8, pages 865-871.
Crossref
Crossref
Jeff Kopelman, Amy S. Budnick, Roy B. Sessions, Marc B. Kramer & George Y. Wong. (2009) Ototoxicity of high‐dose cisplatin by bolus administration in patients with advanced cancers and normal hearing. The Laryngoscope 98:8, pages 858-864.
Crossref
Crossref
Rakesh Sharma, S. B. S. Mann & B. D. Gupta. (1988) Effect of cis-Platinum therapy on audiovestibular function (a study in head & neck and other cancer patients). Indian Journal of Otolaryngology 40:2.
Crossref
Crossref
R. J. A. M. van der Hulst, W. A. Dreschler & N. A. M. Urbanus. (2016) High Frequency Audiometry in Prospective Clinical Research of Ototoxicity Due to Platinum Derivatives. Annals of Otology, Rhinology & Laryngology 97:2, pages 133-137.
Crossref
Crossref
A. Harstrick, R. Guba, J. Casper, D. Reile, H.-U. Hemelt, H. Poliwoda, H. Wilke & H.-J. Schmoll. 1988. Diagnostik und Therapie von Hodentumoren. Diagnostik und Therapie von Hodentumoren
579
586
.
Brian J. Corden. (1987) Reaction of platinum(II) antitumor agents with sulfhydral compounds and the implications for nephrotoxicity. Inorganica Chimica Acta 137:1-2, pages 125-130.
Crossref
Crossref
H. Wynne & K.W. Woodhouse. (1987) 9 The disposition of cytotoxic drugs in the elderly. Baillière's Clinical Haematology 1:2, pages 513-531.
Crossref
Crossref
G. LAURELL, B. ENGSTRÖM, A. HIRSCH & D. BAGGER‐SJÖBÄCK. (2008) Ototoxicity of cisplatin. International Journal of Andrology 10:1, pages 359-362.
Crossref
Crossref
Jill Griffin. (1987) Considerations with cisplatin (Platinol) administration in the office setting for oncology nurses. Seminars in Oncology Nursing 3:1, pages 8-15.
Crossref
Crossref
Sarah E. Barron & Ernest A. Daigneault. (1987) Effect of cisplatin on hair cell morphology and lateral wall Na, K-ATPase activity. Hearing Research 26:2, pages 131-137.
Crossref
Crossref
Vanessa G. Schweitzer, David F. Dolan, Thomas Davidson, Gerald E. Abrams & Ronald Snyder Bs. (2009) Amelioration of Cisplatin‐Induced ototoxicity by fosfomycin. The Laryngoscope 96:9, pages 948-958.
Crossref
Crossref
Matti Anniko & Aron Sobin. (1986) Cisplatin: Evaluation of its ototoxic potential. American Journal of Otolaryngology 7:4, pages 276-293.
Crossref
Crossref
R. A. Tange, W. A. Dreschler & R. J. A. M. Hulst. (1985) The importance of high-tone audiometry in monitoring for ototoxicity. Archives of Oto-Rhino-Laryngology 242:1, pages 77-81.
Crossref
Crossref
Laurie B. Melamed, Mostafa A. Selim & Dov Schuchman. (1985) Cisplatin ototoxicity in gynecologic cancer patients. A preliminary report. Cancer 55:1, pages 41-43.
Crossref
Crossref
R. A. TANGE. (1984) Differences in the cochlear degeneration pattern in the guinea pig as a result of gentamicin and cis-platinum intoxication. Clinical Otolaryngology 9:6, pages 323-327.
Crossref
Crossref
L. G. P. M. Zeijl, E. A. J. G. Conijn, M. Rodenburg, R. A. Tange & M. P. Brocaar. (1984) Analysis of hearing loss due to cis-diamminedichloroplatinum-II. Archives of Oto-Rhino-Laryngology 239:3, pages 255-262.
Crossref
Crossref
Vanessa G. Schweitzer, Joseph E. Hawkins, David J. Lilly, Charles J. Litterst, Gerald Abrams, Julie A. Davis & Michael Christy. (2016)
Ototoxic and Nephrotoxic Effects of Combined Treatment with
cis
‐Diamminedichloroplatinum and Kanamycin in the Guinea Pig
. Otolaryngology–Head and Neck Surgery 92:1, pages 38-49.
Crossref
Crossref
Stephen A. Fausti, Martin A. Schechter, Bruce Z. Rappaport, Richard H. Frey & Robert E. Mass. (1984) Early detection of cisplatin ototoxicity selected case reports. Cancer 53:2, pages 224-231.
Crossref
Crossref
R. A. Tange & V. D. Vuzevski. (1984) Changes in the stria vascularis of the guinea pig due to cis-platinum. Archives of Oto-Rhino-Laryngology 239:1, pages 41-47.
Crossref
Crossref
E. Lehnhardt. 1984. Verhandlungsbericht 1984 der Deutschen Gesellschaft für Hals- Nasen- Ohren-Heilkunde, Kopf- und Hals-Chirurgie. Verhandlungsbericht 1984 der Deutschen Gesellschaft für Hals- Nasen- Ohren-Heilkunde, Kopf- und Hals-Chirurgie
58
218
.
Randall L. Brown, Robert C. Nuss, Ruth Patterson & Jan Irey. (1983) Audiometric monitoring of cis-platinum ototoxicity. Gynecologic Oncology 16:2, pages 254-262.
Crossref
Crossref
S. B. Brummer, L. S. Robblee & F. T. Hambrecht. (1983) CRITERIA FOR SELECTING ELECTRODES FOR ELECTRICAL STIMULATION: THEORETICAL AND PRACTICAL CONSIDERATIONS. Annals of the New York Academy of Sciences 405:1 Cochlear Pros, pages 159-171.
Crossref
Crossref
Susan M. Fleming, Gilmour M. Peters, Arthur W. Weaver, Muhyi Al-Sarraf, Marie E. Schumacher & Mary K. Carey. (1983) Ototoxicity associated with cis-platinum in three chemotherapy multi-drug regimens. Cancer 51:4, pages 610-613.
Crossref
Crossref
V.A. McHaney, G. Thibadoux, F.A. Hayes & A.A. Green. (1983) Hearing loss in children receiving cisplatin chemotherapy. The Journal of Pediatrics 102:2, pages 314-317.
Crossref
Crossref
Teruzo Konishi, Bhola N. Gupta & Jiri Prazma. (1983) Ototoxicity of cis-dichlorodiammine platinum (II) in guinea pigs. American Journal of Otolaryngology 4:1, pages 18-26.
Crossref
Crossref
J.B. Vermorken, T.S. Kapteijn, A.A.M. Hart & H.M. Pinedo. (1983) Ototoxicity of cis-diamminedichloroplatinum (II): Influence of dose, schedule and mode of administration. European Journal of Cancer and Clinical Oncology 19:1, pages 53-58.
Crossref
Crossref
Linda Granowetter, Jeffrey G. Rosenstock & Roger J. Packer. (1983) Enhanced cis-platinum neurotoxicity in pediatric patients with brain tumors. Journal of Neuro-Oncology 1:4, pages 293-297.
Crossref
Crossref
R. A. Tange, E. A. J. G. Conijn & L. G. P. M. Zeijl. (1982) The cortitoxic effects of cis-platinum in the guinea pigDer ototoxische Effekt von Cis-Platin beim Meerschweinchen. Archives of Oto-Rhino-Laryngology 237:1, pages 17-26.
Crossref
Crossref
William E. Evans, Gary C. Yee, William R. Crom, Charles B. Pratt & Alexander A. Green. (2016) Clinical Pharmacology of Bleomycin and Cisplatin. Drug Intelligence & Clinical Pharmacy 16:6, pages 448-458.
Crossref
Crossref
William E. Evans, Gary C. Yee, William R. Crom, Charles B. Pratt & Alexander A. Green. (2006) Clinical pharmacology of bleomycin and cisplatin. Head & Neck Surgery 4:2, pages 98-110.
Crossref
Crossref
Don J. Hall, Robert Diasio & Dean R. Goplerud. (1981) cis-Platinum in gynecologic cancer. American Journal of Obstetrics and Gynecology 141:3, pages 309-312.
Crossref
Crossref
Charles H. PippittJr.Jr., Hyman B. Muss, Howard D. Homesley & Vernon W. Jobson. (1981) Cisplatin-associated cortical blindness. Gynecologic Oncology 12:2, pages 253-255.
Crossref
Crossref
Scott A. Estrem, Richard W. Babin, Jai H. Ryu & Kenneth C. Moore. (2016) Cis‐Diamminedichloroplatinum (II) Ototoxicity in the Guinea Pig. Otolaryngology–Head and Neck Surgery 89:4, pages 638-645.
Crossref
Crossref
Leonard P. Rybak. (2007) Cis-platinum associated hearing loss. The Journal of Laryngology & Otology 95:7, pages 745-747.
Crossref
Crossref
Steven D. Schaefer, Charles G. Wright, Jimmy D. Post & Eugene P. Frenkel. (1981) Cis-platinum vestibular toxicity. Cancer 47:5, pages 857-859.
Crossref
Crossref
Nila V. Aguilar‐Markulis, Summolu Beckley, Roger Priore & Curtis Mettlin. (2006) Auditory toxicity effects of long‐term cis‐dichlorodiammineplatinum II therapy in genitourinary cancer patients. Journal of Surgical Oncology 16:2, pages 111-123.
Crossref
Crossref